{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:34:28Z","timestamp":1792510468004,"version":"4.5.0"},"reference-count":120,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Cardiovascular disease remains a leading cause of death and morbidity in kidney transplant recipients and a common reason for post-transplant hospitalization. Several traditional and nontraditional cardiovascular risk factors exist, and many of them present pretransplant and worsened, in part, due to the addition of immunosuppression post-transplant. We discuss optimal strategies for identification and treatment of these risk factors, including the emerging role of sodium-glucose cotransporter 2 inhibitors in post-transplant diabetes and cardiovascular disease. We present common types of cardiovascular disease observed after kidney transplant, including coronary artery disease, heart failure, pulmonary hypertension, arrhythmia, and valvular disease. We also discuss screening, treatment, and prevention of post-transplant cardiac disease. We highlight areas of future research, including the need for goals and best medications for risk factors, the role of biomarkers, and the role of screening and intervention.<\/jats:p>","DOI":"10.2215\/cjn.00520121","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T11:18:14Z","timestamp":1632395894000},"page":"1878-1889","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":97,"title":["Post-Transplant Cardiovascular Disease"],"prefix":"10.2215","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-3947","authenticated-orcid":false,"given":"Kelly A.","family":"Birdwell","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyeon","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","article-title":"Cardiovascular morbidity and mortality after kidney transplantation","volume":"28","author":"Stoumpos","year":"2015","journal-title":"Transpl Int"},{"key":"B3-20241015","article-title":"OPTN\/SRTR 2017 Annual Data Report. Scientific Registry of Transplant Recipients"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-0012.2004.00235.x","article-title":"Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up","volume":"18","author":"Aakhus","year":"2004","journal-title":"Clin Transplant"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/TXD.0000000000000640","article-title":"Patterns of care and outcomes in cardiovascular disease after kidney transplantation in the United States","volume":"3","author":"Mathur","year":"2017","journal-title":"Transplant Direct"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","article-title":"ISN Global Kidney Health Summit participants: Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy","volume":"390","author":"Levin","year":"2017","journal-title":"Lancet"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/CIRCULATIONAHA.115.008718","article-title":"Worldwide exposures to cardiovascular risk factors and associated health effects: Current knowledge and data gaps","volume":"133","author":"Tzoulaki","year":"2016","journal-title":"Circulation"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurheartj\/ehy422","article-title":"Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: A retrospective analysis","volume":"40","author":"O\u2019Shaughnessy","year":"2019","journal-title":"Eur Heart J"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","article-title":"Hypertension after kidney transplantation","volume":"43","author":"Kasiske","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"E438","DOI":"10.1111\/j.1399-0012.2012.01676.x","article-title":"Inadequacy of cardiovascular risk factor management in chronic kidney transplantation\u2014Evidence from the FAVORIT study","volume":"26","author":"Carpenter","year":"2012","journal-title":"Clin Transplant"},{"key":"B12-20241015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/TP.0b013e3182516cdc","article-title":"A cardiovascular risk calculator for renal transplant recipients","volume":"94","author":"Soveri","year":"2012","journal-title":"Transplantation"},{"key":"B13-20241015","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B14-20241015","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients. Available at: https:\/\/kdigo.org\/guidelines\/"},{"key":"B15-20241015","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"B16-20241015","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1038\/s41598-019-46991-2","article-title":"Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation","volume":"9","author":"Pagonas","year":"2019","journal-title":"Sci Rep"},{"key":"B17-20241015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.TP.0000437672.78716.28","article-title":"Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers","volume":"97","author":"Opelz","year":"2014","journal-title":"Transplantation"},{"key":"B18-20241015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: A meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B19-20241015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2009.10.058","article-title":"Cigarette smoking, kidney function, and mortality after live donor kidney transplant","volume":"55","author":"Nogueira","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B20-20241015","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1681\/ASN.V114753","article-title":"Cigarette smoking in renal transplant recipients","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B21-20241015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/TP.0b013e3182336095","article-title":"Effect of smoking on kidney transplant outcomes: Analysis of the United States Renal Data System","volume":"92","author":"Hurst","year":"2011","journal-title":"Transplantation"},{"key":"B22-20241015","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"B23-20241015","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"B24-20241015","article-title":"KDIGO Clinical Practice Guideline for Lipid Management in CKD: Summary of recommendation statements and clinical approach to the patient"},{"key":"B25-20241015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1399-0012.2009.01194.x","article-title":"Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients","volume":"24","author":"Luan","year":"2010","journal-title":"Clin Transplant"},{"key":"B26-20241015","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/j.1523-1755.2005.00349.x","article-title":"New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation","volume":"67","author":"Cosio","year":"2005","journal-title":"Kidney Int"},{"key":"B27-20241015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"B28-20241015","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Am J Transplant"},{"key":"B29-20241015","article-title":"Scientific Registry of Transplant Recipients"},{"key":"B30-20241015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.ki.5000116","article-title":"The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events","volume":"69","author":"Hjelmesaeth","year":"2006","journal-title":"Kidney Int"},{"key":"B31-20241015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DMSO.S19027","article-title":"New onset diabetes after transplantation (NODAT): An overview","volume":"4","author":"Pham","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B32-20241015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2010.09.003","article-title":"New-onset diabetes after transplantation: Risk factors and clinical impact","volume":"37","author":"R\u00e4kel","year":"2011","journal-title":"Diabetes Metab"},{"key":"B33-20241015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2310\/JIM.0b013e3181e61a64","article-title":"New-onset diabetes after renal transplantation","volume":"58","author":"Mora","year":"2010","journal-title":"J Investig Med"},{"key":"B34-20241015","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"B35-20241015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1432-2277.2009.00955.x","article-title":"Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up","volume":"23","author":"Lee","year":"2010","journal-title":"Transpl Int"},{"key":"B36-20241015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2215\/CJN.00620206","article-title":"Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes","volume":"2","author":"Burroughs","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B37-20241015","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/ajt.14665","article-title":"Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation","volume":"18","author":"Wissing","year":"2018","journal-title":"Am J Transplant"},{"key":"B38-20241015","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/tri.12605","article-title":"Does belatacept improve outcomes for kidney transplant recipients? A systematic review","volume":"28","author":"Talawila","year":"2015","journal-title":"Transpl Int"},{"key":"B39-20241015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfr374","article-title":"Very early steroid withdrawal or complete avoidance for kidney transplant recipients: A systematic review","volume":"27","author":"Pascual","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B40-20241015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181605ebf","article-title":"Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia","volume":"85","author":"Sharif","year":"2008","journal-title":"Transplantation"},{"key":"B41-20241015","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1600-6143.2011.03550.x","article-title":"Should metformin be our antiglycemic agent of choice post-transplantation?","volume":"11","author":"Sharif","year":"2011","journal-title":"Am J Transplant"},{"key":"B42-20241015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"CANVAS Program Collaborative Group: Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"B43-20241015","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME Investigators: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"B44-20241015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"DECLARE\u2013TIMI 58 Investigators: Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"B45-20241015","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"CREDENCE Trial Investigators: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"B46-20241015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.15223","article-title":"Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety","volume":"19","author":"Schwaiger","year":"2019","journal-title":"Am J Transplant"},{"key":"B47-20241015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus","volume":"42","author":"Halden","year":"2019","journal-title":"Diabetes Care"},{"key":"B48-20241015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.transproceed.2019.11.007","article-title":"Outcomes of SGLT2 inhibitors use in diabetic renal transplant patients","volume":"52","author":"AlKindi","year":"2020","journal-title":"Transplant Proc"},{"key":"B49-20241015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1159\/000501854","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibition in kidney transplant recipients with diabetes mellitus","volume":"44","author":"Mahling","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"B50-20241015","first-page":"E47","article-title":"Efficacy and safety of SGLT-2 inhibitors for treatment of diabetes mellitus among kidney transplant patients: A systematic review and meta-analysis","volume":"8","author":"Chewcharat","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"B51-20241015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e31817ef0f9","article-title":"Obesity and cardiac risk after kidney transplantation: Experience at one center and comprehensive literature review","volume":"86","author":"Lentine","year":"2008","journal-title":"Transplantation"},{"key":"B52-20241015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.jrn.2013.09.002","article-title":"Obesity in kidney transplantation","volume":"24","author":"Chan","year":"2014","journal-title":"J Ren Nutr"},{"key":"B53-20241015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1681\/ASN.2011050476","article-title":"The impact of renal function on outcomes of bariatric surgery","volume":"23","author":"Turgeon","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B54-20241015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11695-018-3604-2","article-title":"National postoperative bariatric surgery outcomes in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Cohen","year":"2019","journal-title":"Obes Surg"},{"key":"B55-20241015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/ajt.14463","article-title":"Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients","volume":"18","author":"Kim","year":"2018","journal-title":"Am J Transplant"},{"key":"B56-20241015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ajt.15650","article-title":"Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy","volume":"20","author":"Kassam","year":"2020","journal-title":"Am J Transplant"},{"key":"B57-20241015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.soard.2019.01.034","article-title":"Survival benefit in bariatric surgery kidney recipients may be mediated through effects on kidney graft function and improvement of co-morbidities: A case-control study","volume":"15","author":"Schindel","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"B58-20241015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12659\/AOT.913649","article-title":"Pre-transplant left ventricular geometry and major adverse cardiovascular events after kidney transplantation","volume":"24","author":"Malyala","year":"2019","journal-title":"Ann Transplant"},{"key":"B59-20241015","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12864","article-title":"Longitudinal assessment of cardiac morphology and function following kidney transplantation","volume":"31","author":"Kensinger","year":"2017","journal-title":"Clin Transplant"},{"key":"B60-20241015","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/ndt\/gfv354","article-title":"Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: A long-term prospective cohort study","volume":"31","author":"Paoletti","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B61-20241015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/TP.0000000000000903","article-title":"The kidney-vascular-bone axis in the chronic kidney disease-mineral bone disorder","volume":"100","author":"Seifert","year":"2016","journal-title":"Transplantation"},{"key":"B62-20241015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism","volume":"99","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplantation"},{"key":"B63-20241015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00423-020-01953-5","article-title":"Dutch Hyperparathyroidism Study Group: Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: A propensity-matched analysis","volume":"405","author":"Koh","year":"2020","journal-title":"Langenbecks Arch Surg"},{"key":"B64-20241015","article-title":"Association between treatment of secondary hyperparathyroidism and posttransplant outcomes","author":"Mathur","journal-title":"Transplantation"},{"key":"B65-20241015","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B66-20241015","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00268-019-05020-z","article-title":"Cardiovascular and cerebrovascular events after parathyroidectomy in patients on renal replacement therapy","volume":"43","author":"Ivarsson","year":"2019","journal-title":"World J Surg"},{"key":"B67-20241015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1523-1755.2004.00751.x","article-title":"Predicting coronary heart disease in renal transplant recipients: A prospective study","volume":"66","author":"Ducloux","year":"2004","journal-title":"Kidney Int"},{"key":"B68-20241015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.07860814","article-title":"A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation","volume":"10","author":"Yilmaz","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B69-20241015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12882-016-0369-5","article-title":"Long term evolution of endothelial function during kidney transplantation","volume":"17","author":"Kensinger","year":"2016","journal-title":"BMC Nephrol"},{"key":"B70-20241015","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/ajt.12852","article-title":"Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: A systematic review and meta-analysis","volume":"14","author":"Murakami","year":"2014","journal-title":"Am J Transplant"},{"key":"B71-20241015","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.13853","article-title":"Comparison of utilization and clinical outcomes for belatacept- and tacrolimus-based immunosuppression in renal transplant recipients","volume":"16","author":"Wen","year":"2016","journal-title":"Am J Transplant"},{"key":"B72-20241015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","article-title":"Five-year safety and efficacy of belatacept in renal transplantation","volume":"21","author":"Vincenti","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B73-20241015","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B74-20241015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1681\/ASN.2005020189","article-title":"Cardiovascular risk evaluation before kidney transplantation","volume":"16","author":"Fishbane","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B75-20241015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ccd.22656","article-title":"Coronary angiography is a better predictor of mortality than noninvasive testing in patients evaluated for renal transplantation","volume":"76","author":"Enkiri","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"B76-20241015","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"ISCHEMIA-CKD Research Group: Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"B77-20241015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2012.05.008","article-title":"American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease: Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"60","author":"Lentine","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B78-20241015","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"B79-20241015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1681\/ASN.2004070580","article-title":"Incidence and predictors of myocardial infarction after kidney transplantation","volume":"16","author":"Lentine","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B80-20241015","article-title":"Improving Global Outcomes: KDIGO clinical practice guideline for the care of kidney transplant recipients"},{"key":"B81-20241015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000658-199908000-00014","article-title":"Outcome after myocardial revascularization and renal transplantation: A 25-year single-institution experience","volume":"230","author":"Ferguson","year":"1999","journal-title":"Ann Surg"},{"key":"B82-20241015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-6143.2012.04317.x","article-title":"Cardiac troponin T before and after kidney transplantation: Determinants and implications for posttransplant survival","volume":"13","author":"Keddis","year":"2013","journal-title":"Am J Transplant"},{"key":"B83-20241015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration: Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: A meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Herrington","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B84-20241015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.ajkd.2016.01.019","article-title":"Aspirin use and incident cardiovascular disease, kidney failure, and death in stable kidney transplant recipients: A post hoc analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial","volume":"68","author":"Dad","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B85-20241015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid management in patients with chronic kidney disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B86-20241015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B87-20241015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B88-20241015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11886-003-0050-z","article-title":"The prognostic significance of renal dysfunction in patients with chronic systolic heart failure","volume":"5","author":"Laskar","year":"2003","journal-title":"Curr Cardiol Rep"},{"key":"B89-20241015","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Conference Participants: Heart failure in chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int"},{"key":"B90-20241015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jcmg.2017.05.004","article-title":"Impact of end-stage renal disease on left and right ventricular mechanics: Does kidney transplantation reverse the abnormalities?","volume":"10","author":"Xu","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"B91-20241015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2018.07.088","article-title":"Reduced global longitudinal strain is associated with increased risk of cardiovascular events or death after kidney transplant","volume":"272","author":"Fujikura","year":"2018","journal-title":"Int J Cardiol"},{"key":"B92-20241015","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/TP.0000000000003125","article-title":"Pretransplant NT-proBNP, dialysis vintage, and posttransplant mortality in kidney transplant recipients","volume":"104","author":"Yeung","year":"2020","journal-title":"Transplantation"},{"key":"B93-20241015","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.transproceed.2014.08.020","article-title":"N-terminal pro-B-type natriuretic peptide (NT-proBNP) assessment in the first year after renal transplantation and its relationship with graft function and left ventricular hypertrophy","volume":"46","author":"Slubowska","year":"2014","journal-title":"Transplant Proc"},{"key":"B94-20241015","doi-asserted-by":"crossref","first-page":"e005336","DOI":"10.1161\/JAHA.116.005336","article-title":"CRIC (Chronic Renal Insufficiency Cohort) Investigators: Risk factors for heart failure in patients with chronic kidney disease: The CRIC (Chronic Renal Insufficiency Cohort) study","volume":"6","author":"He","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B95-20241015","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"B96-20241015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/TP.0000000000001043","article-title":"Evaluation and management of pulmonary hypertension in kidney transplant candidates and recipients: Concepts and controversies","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"B97-20241015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/0886022X.2013.766559","article-title":"Pulmonary hypertension in dialysis patients","volume":"35","author":"Kosmadakis","year":"2013","journal-title":"Ren Fail"},{"key":"B98-20241015","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1053\/ajkd.2002.34932","article-title":"Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistula","volume":"40","author":"Clarkson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B99-20241015","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ajt.12197","article-title":"Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation","volume":"13","author":"Lenihan","year":"2013","journal-title":"Am J Transplant"},{"key":"B100-20241015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.00920805","article-title":"Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation","volume":"1","author":"Lentine","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B101-20241015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ndt\/gfz053","article-title":"Cardiovascular disease in the kidney transplant recipient: Epidemiology, diagnosis and management strategies","volume":"34","author":"Rangaswami","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"B102-20241015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5414\/CNP59079","article-title":"Hospitalized valvular heart disease in patients on renal transplant waiting list: Incidence, clinical correlates and outcomes","volume":"59","author":"Abbott","year":"2003","journal-title":"Clin Nephrol"},{"key":"B103-20241015","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.109.912170","article-title":"Survival of kidney transplantation patients in the United States after cardiac valve replacement","volume":"121","author":"Sharma","year":"2010","journal-title":"Circulation"},{"key":"B104-20241015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jjcc.2013.01.016","article-title":"Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement","volume":"61","author":"Fox","year":"2013","journal-title":"J Cardiol"},{"key":"B105-20241015","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1038\/s41598-017-14486-7","article-title":"Transfemoral transcatheter aortic valve implantation in patients with end-stage renal disease and kidney transplant recipients","volume":"7","author":"Al-Rashid","year":"2017","journal-title":"Sci Rep"},{"key":"B106-20241015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1432-2277.2011.01237.x","article-title":"Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: A nationwide longitudinal study","volume":"24","author":"Jacquet","year":"2011","journal-title":"Transpl Int"},{"key":"B107-20241015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4239\/wjd.v6.i3.445","article-title":"New-onset diabetes mellitus after kidney transplantation: Current status and future directions","volume":"6","author":"Palepu","year":"2015","journal-title":"World J Diabetes"},{"key":"B108-20241015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B109-20241015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2215\/CJN.11261114","article-title":"Patient characteristics and outcomes by GN subtype in ESRD","volume":"10","author":"O\u2019Shaughnessy","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B110-20241015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7326\/M18-1570","article-title":"Renal transplantation and survival among patients with lupus nephritis: A cohort study","volume":"170","author":"Jorge","year":"2019","journal-title":"Ann Intern Med"},{"key":"B111-20241015","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.2016020126","article-title":"Kidney transplantation outcomes across GN subtypes in the United States","volume":"28","author":"O\u2019Shaughnessy","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B112-20241015","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.TP.0000120949.86038.62","article-title":"Weight gain after renal transplantation is a risk factor for patient and graft outcome","volume":"77","author":"el-Agroudy","year":"2004","journal-title":"Transplantation"},{"key":"B113-20241015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12882-015-0092-7","article-title":"Assessment of arterial stiffness using pulse wave velocity in tacrolimus users the first year post kidney transplantation: A prospective cohort study","volume":"16","author":"Birdwell","year":"2015","journal-title":"BMC Nephrol"},{"key":"B114-20241015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12659\/AOT.908168","article-title":"Cyclosporin A aggravates calcification of vascular smooth muscle cells under high-glucose conditions with a calcifying medium","volume":"23","author":"Kim","year":"2018","journal-title":"Ann Transplant"},{"key":"B115-20241015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MNH.0b013e32833e04f5","article-title":"Preemptive transplantation and the transplant first initiative","volume":"19","author":"Davis","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B116-20241015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ndt\/gfy039","article-title":"Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: Results from the French transplant database","volume":"34","author":"Prezelin-Reydit","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"B117-20241015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2016.10.019","article-title":"Urine fibrosis markers and risk of allograft failure in kidney transplant recipients: A case-cohort ancillary study of the FAVORIT trial","volume":"69","author":"Ix","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B118-20241015","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/ajt.14284","article-title":"Urinary markers of fibrosis and risk of cardiovascular events and death in kidney transplant recipients: The FAVORIT trial","volume":"17","author":"Park","year":"2017","journal-title":"Am J Transplant"},{"key":"B119-20241015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2018.05.015","article-title":"Albuminuria and allograft failure, cardiovascular disease events, and all-cause death in stable kidney transplant recipients: A cohort analysis of the FAVORIT trial","volume":"73","author":"Weiner","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"B120-20241015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/ajt.15191","article-title":"Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients","volume":"19","author":"Pihlstr\u00f8m","year":"2019","journal-title":"Am J Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.00520121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:52Z","timestamp":1786369432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.00520121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":120,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00520121","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}